Boditech Med Inc. (KOSDAQ:206640)
13,530
+120 (0.89%)
At close: Dec 5, 2025
Boditech Med Revenue
Boditech Med had revenue of 39.95B KRW in the quarter ending September 30, 2025, with 6.26% growth. This brings the company's revenue in the last twelve months to 151.75B, up 6.97% year-over-year. In the year 2024, Boditech Med had annual revenue of 138.16B with 2.94% growth.
Revenue (ttm)
151.75B
Revenue Growth
+6.97%
P/S Ratio
1.94
Revenue / Employee
280.50M
Employees
541
Market Cap
294.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 138.16B | 3.94B | 2.94% |
| Dec 31, 2023 | 134.22B | 16.14B | 13.67% |
| Dec 31, 2022 | 118.08B | -39.63B | -25.13% |
| Dec 31, 2021 | 157.71B | 13.58B | 9.42% |
| Dec 31, 2020 | 144.13B | 71.33B | 97.99% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |